Valuation: Artivion, Inc.

Market Cap 1.16B 1.03B 945M 859M 1.61B 109B 1.65B 11.29B 4.53B 57.82B 4.34B 4.25B 183B P/E 2026 *
-67.7x
P/E 2027 * 87.1x
Enterprise Value 1.16B 1.03B 945M 859M 1.61B 109B 1.65B 11.29B 4.53B 57.82B 4.34B 4.25B 183B EV / Sales 2026 *
2.36x
EV / Sales 2027 * 2.13x
Free-Float
89.42%
Yield 2026 *
-
Yield 2027 * -
1 day+11.56%
1 week+15.30%
Current month+17.14%
1 month+18.56%
3 months-3.71%
6 months-26.95%
Current year-42.01%
1 week 21.85
Extreme 21.85
26.69
1 month 20.21
Extreme 20.21
26.69
Current year 19.16
Extreme 19.16
46.84
1 year 19.16
Extreme 19.16
48.25
3 years 13.18
Extreme 13.18
48.25
5 years 9.64
Extreme 9.64
48.25
10 years 9.64
Extreme 9.64
48.25
Manager TitleAgeSince
Chief Executive Officer 59 01/09/2014
Director of Finance/CFO 53 03/12/2023
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 71 30/11/2003
Director/Board Member 66 30/11/2003
Director/Board Member 61 30/04/2012
Date Insider Type Main position Quantity % Market Cap. Importance
10/09/26 Sell

General Counsel

-11,480 0.0235%
03/09/26 Sell

General Counsel

-1,493 0.0031%
19/08/26 Sell

Chief Executive Officer

-70,000 0.1442%
Change 5-day change 1-year change 3-year change Capi.($)
+11.56%+15.30%-42.11%+85.87% 1.16B
+5.59%+12.04%-6.73%+20.52% 189B
+6.15%+11.72%+16.36%+44.65% 121B
+9.37%+12.68%-5.17%+22.96% 118B
+2.63%+4.02%-40.35%+8.53% 94.78B
+3.96%+8.80%+3.83%+81.38% 64.98B
+5.56%+7.26%+17.99%-19.20% 53.98B
+3.94%+24.46%-3.37%+62.72% 52.94B
+0.18%-7.36%-2.67%+55.91% 52.3B
+5.75%+9.90%+7.33%-5.58% 35.25B
Average +4.89%+4.16%-5.49%+35.78% 78.4B
Weighted average by Cap. +3.90%+4.39%-3.34%+29.61%

Financials

2026 *2027 *
Net sales 491M 437M 401M 364M 685M 46.37B 701M 4.79B 1.92B 24.54B 1.84B 1.8B 77.74B 544M 484M 444M 404M 759M 51.38B 776M 5.31B 2.13B 27.19B 2.04B 2B 86.14B
Net income -15.84M -14.12M -12.95M -11.77M -22.12M -1.5B -22.62M -155M -62.03M -792M -59.47M -58.19M -2.51B 12.11M 10.79M 9.9M 8.99M 16.91M 1.14B 17.29M 118M 47.42M 606M 45.45M 44.48M 1.92B
Net Debt - -
Projected Income Statement - Annual - Artivion, Inc.
Logo Artivion, Inc.
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.
Employees
1,800
Date Price Change Volume
04/11/26 US$26.45 +11.56% 1,085,609
03/11/26 US$23.71 +0.55% 645,726
02/11/26 US$23.58 +4.43% 626,161
30/10/26 US$22.58 -3.67% 627,384
29/10/26 US$23.44 +2.27% 418,196
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - Artivion, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
26.45USD
Average target price
40.91USD
Spread / Average Target
+54.67%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Artivion, Inc.
  1. Stock Market
  2. Stocks
  3. AORT Stock